Transplantation with unrelated bone marrow in leukemic patients above 40 years of age.
Ringdén
O
O
Department of Clinical Immunology, Huddinge Hospital, Sweden.
Remberger
M
M
Mattsson
J
J
Aschan
J
J
Hägglund
H
H
Carlens
S
S
Lönnqvist
B
B
Sparrelid
E
E
Ljungman
P
P
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D016026:Bone Marrow Transplantation / Q000276:immunology / Q000401:mortality; D002648:Child; D002675:Child, Preschool; D006086:Graft vs Host Disease / Q000453:epidemiology; D006650:Histocompatibility Testing; D006801:Humans; D015994:Incidence; D007223:Infant; D007938:Leukemia / Q000097:blood / Q000628:therapy*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D007951:Leukemia, Myeloid / Q000628:therapy; D007958:Leukocyte Count; D008875:Middle Aged; D009504:Neutrophils; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D011336:Probability; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate